Dr Mansukh Mandaviya, Union Minister for Chemicals & Fertilizers and Health & Family Welfare virtually inaugurated 27 greenfield bulk drug park projects and 13 greenfield manufacturing plants for medical devices recently.
Addressing the gathering, Dr Mandaviya said, “Medicines are an essential requirement for any society. During the COVID-19 pandemic, the dangers of supply chain getting affected, the risks of being highly dependent on imports of critical resources like bulk drugs and medical devices and its potential effects on India’s pharma and MedTech sector led to a lot of brainstorming within the Union Government. The Production Linked Incentive (PLI) scheme is a result of these wide-ranging discussions”
Expressing his elation at the inauguration of these greenfield projects under the PLI scheme, the Union Minister said, “it is noteworthy that today India has not only reduced its dependence on medicines, API and medical devices, the country is also emerging as a major exporter of these products, thanks to the success of the PLI scheme.”
Dr Mandaviya said that “the PLI-I scheme of the Union Government identified 48 critical bulk drugs for manufacturing locally. The success of this inaugural scheme led the government to launch the Rs. 15,000 crore PLI-II scheme which envisaged to increase our cost competitiveness for medicines and medical products in the international market”.
Highlighting the Union Government’s efforts towards making India atmanirbhar in the field of critical medicines and active pharmaceutical ingredients (API), the Union Minister stated the example of Penicillin G, a widely used drug which were locally manufactured in India until the late 1980s. Due to globalisation, the import of Penicillin G led to the closure of all such plants in India. He highlighted that the Union Government is working on bringing back production of Penicillin G in India after three decades.
Rajesh Kumar Singh, Secretary, Dept. for Promotion of Industry and Internal Trade noted that Union Government approached the COVID-19 pandemic with a mindset to turn the crisis into an opportunity. He highlighted the efforts of the administration in enhancing self-reliance, innovation and infrastructure, including both physical and digital as displays of such a vision.
R K Singh stated that the PLI scheme was also envisaged through the same vision to bring in localisation and value addition to India’s pharma and MedTech industry and simultaneously also reduce over-dependence on critical resources from certain geographies.
Dr. Arunish Chawla, Secretary; Dept. of Pharmaceuticals gave a detailed presentation on the PLI scheme of the Union Government. He said that the drug and pharmaceutical industry in India witnessed a 12 per cent compound annual growth rate (CAGR) in the last 10 years. He also highlighted that under the PLI scheme, as many as 1800 pharmaceutical products and formulations and 22 bulk drugs will be manufactured in India.
It was also informed that when the PLI scheme came in, India imported 90% of medical devices. After the introduction of the PLI scheme, the net imports of medical devices decreased for the first time in 2023.
The following are the details of bulk drug plants inaugurated :
Addressing the gathering, Dr Mandaviya said, “Medicines are an essential requirement for any society. During the COVID-19 pandemic, the dangers of supply chain getting affected, the risks of being highly dependent on imports of critical resources like bulk drugs and medical devices and its potential effects on India’s pharma and MedTech sector led to a lot of brainstorming within the Union Government. The Production Linked Incentive (PLI) scheme is a result of these wide-ranging discussions”
Expressing his elation at the inauguration of these greenfield projects under the PLI scheme, the Union Minister said, “it is noteworthy that today India has not only reduced its dependence on medicines, API and medical devices, the country is also emerging as a major exporter of these products, thanks to the success of the PLI scheme.”
Dr Mandaviya said that “the PLI-I scheme of the Union Government identified 48 critical bulk drugs for manufacturing locally. The success of this inaugural scheme led the government to launch the Rs. 15,000 crore PLI-II scheme which envisaged to increase our cost competitiveness for medicines and medical products in the international market”.
Highlighting the Union Government’s efforts towards making India atmanirbhar in the field of critical medicines and active pharmaceutical ingredients (API), the Union Minister stated the example of Penicillin G, a widely used drug which were locally manufactured in India until the late 1980s. Due to globalisation, the import of Penicillin G led to the closure of all such plants in India. He highlighted that the Union Government is working on bringing back production of Penicillin G in India after three decades.
Rajesh Kumar Singh, Secretary, Dept. for Promotion of Industry and Internal Trade noted that Union Government approached the COVID-19 pandemic with a mindset to turn the crisis into an opportunity. He highlighted the efforts of the administration in enhancing self-reliance, innovation and infrastructure, including both physical and digital as displays of such a vision.
R K Singh stated that the PLI scheme was also envisaged through the same vision to bring in localisation and value addition to India’s pharma and MedTech industry and simultaneously also reduce over-dependence on critical resources from certain geographies.
Dr. Arunish Chawla, Secretary; Dept. of Pharmaceuticals gave a detailed presentation on the PLI scheme of the Union Government. He said that the drug and pharmaceutical industry in India witnessed a 12 per cent compound annual growth rate (CAGR) in the last 10 years. He also highlighted that under the PLI scheme, as many as 1800 pharmaceutical products and formulations and 22 bulk drugs will be manufactured in India.
It was also informed that when the PLI scheme came in, India imported 90% of medical devices. After the introduction of the PLI scheme, the net imports of medical devices decreased for the first time in 2023.
The following are the details of bulk drug plants inaugurated :
| Sl. No. | Name of the Company | Bulk Drugs | Location |
| 1 | Meghmani LLP | Para Amino Phenol | Dahej, Gujarat |
| 2 | Sadhana Nitro Chem Ltd. | Para Amino Phenol | Raigad, Maharashtra |
| 3 | Emmennar Pharma Pvt. Ltd. | 1,1 Cyclohexane Diacetic Acid (CDA) | Sangareddy, Telangana |
| 4 | Hindys Lab Pvt. Ltd. |
[TD]
[TD]
1,1 Cyclohexane Diacetic Acid (CDA)
[/TD][TD]
Nalgonda, Telangana
[/TD][TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[TD]
[TD]
[/TR]
[TR]
[TD]
[TD]
[/TR]
[TD]
5
[/TD][TD]
Acyclovir
[/TD][/TR]
[TR]
[TD]
6
[/TD][TD]
Kreative Actives Private Limited
[/TD][TD]
Diclofenac Sodium
[/TD][TD]
Visakhapatnam, Andhra Pradesh
[/TD][/TR]
[TR]
[TD]
7
[/TD][TD]
Dasami Lab Pvt. Ltd.
[/TD][TD]
[TD]
[/TR]Carbamazepine
[/TD][TD]
Nalgonda, Telangana
[/TD][TR]
[TD]
8
[/TD][TD]
Oxcarbazepine
[/TD][/TR]
[TR]
[TD]
9
[/TD][TD]
Hetero Drugs Limited
[/TD][TD]
[TD]
[/TR]Carbidopa
[/TD][TD]
Visakhapatnam, Andhra Pradesh
[/TD][TR]
[TD]
10
[/TD][TD]
Levodopa
[/TD][/TR]
[TR]
[TD]
11
[/TD][TD]
Levofloxacin
[/TD][TD]
Sangareddy, Telangana
[/TD][/TR]
[TR]
[TD]
12
[/TD][TD]
[/TR]Oxcarbazepine
[/TD][TR]
[TD]
13
[/TD][TD]
Honour Lab Limited
[/TD][TD]
Levetiracetam
[/TD][TD]
Sangareddy, Telangana
[/TD][/TR]
[TR]
[TD]
14
[/TD][TD]
Valsartan
[/TD][/TR]
[TR]
[TD]
15
[/TD][TD]
Lopinavir
[/TD][TD]
Visakhapatnam, Andhra Pradesh
[/TD][/TR]
[TR]
[TD]
16
[/TD][TD]
Vitamin B6
[/TD][/TR]
[TR]
[TD]
17
[/TD][TD]
Anasia Lab Private Limited
[/TD][TD]
Losartan
[/TD][TD]
Nalgonda, Telangana
[/TD][/TR]
[TR]
[TD]
18
[/TD][TD]
Olmesartan
[/TD][/TR]
[TR]
[TD]
19
[/TD][TD]
Andhra Organics Limited
[/TD][TD]
Sulfadiazine
[/TD][TD]
Srikukalam, Andhra Pradesh
[/TD][/TR]
[TR]
[TD]
20
[/TD][TD]
Telmisartan
[/TD][/TR]
[TR]
[TD]
21
[/TD][TD]
Amoli Organics Private Limited
[/TD][TD]
Diclofenac Sodium
[/TD][TD]
Vapi, Gujarat
[/TD][/TR]
[TR]
[TD]
22
[/TD][TD]
Symbiotec Pharmalab Private Limited
[/TD][TD]
Prednisolone
[/TD][TD]
Dhar, M.P.
[/TD][/TR]
[TR]
[TD]
23
[/TD][TD]
Hazelo Lab Pvt. Ltd.
[/TD][TD]
Vitamin B6
[/TD][TD]
Yadadri Dist., Telangana
[/TD][/TR]
[TR]
[TD]
24
[/TD][TD]
Aviran Pharmachem Private Limited
[/TD][TD]
Artesunate
[/TD][TD]
Mehsana, Gujarat
[/TD][/TR]
[TR]
[TD]
25
[/TD][TD]
Centrient Pharmaceuticals India Private Limited
[/TD][TD]
Atorvastatin
[/TD][TD]
Nawanshahr, Punjab
[/TD][/TR]
[TR]
[TD]
26
[/TD][TD]
Globela Industries Pvt. Ltd
[/TD][TD]
Norfloxacin
[/TD][TD]
Bharuch, Gujarat
[/TD][/TR]
[TR]
[TD]
27
[/TD][TD]
Ofloxacin
[/TD][/TR]
The following are the details of medical devices plants inaugurated:
| Sl. No. | Applicants Name | Product | Location of Projects |
| 1 | Panacea Medical Technologies Private Limited | Linear Accelerator (LINAC), Rotational Cobalt Machine | Kolar, Karnataka |
| 2 | Philips Global Business Services LLP | MRI Coils | Taluka KHED, Pune, Maharashtra |
| 3 | Siemens Healthcare Private Limited | CT Scan and MRI | Hosur Road, Bengaluru |
| 4 | Wipro GE Healthcare Private Limited TS 2 | CT Scan, Cath Lab and Ultrasonography | Bengaluru, Karnataka |
| 5 | Trivitron Healthcare Private LImited | X Ray Equipment, C-Arm, mammography and Ultrasonography | Raigad, Maharashtra & Vizag, A.P. |
| 6 | Allied Medical Limited | Anaesthesia workstation, Anaesthesia Unit Gas Scavengers, Anaesthesia Kits, Masks —Anaesthesia, Anaesthesia Unit Vaporizers, Anaesthesia Unit Ventilators, Automated external defibrillators (AEDs), Bi- Phasic Defibrillators, Infusion pumps – Syringe and Volumetric, etc. | Karoli, Alwar, Rajasthan |
| 7 | Microtek New Technologies Private Limited | Oxygen Concentrators | Baddi – Solan Himachal Pradesh |
| 8 | Nipro India Corporation Private Limited | Dialyzer | Satara, Maharashtra |
| 9 | Poly Medicure Limited | Dialyzer, Dialysis Machine, Peritoneal Dialysis kits, Fistula, Blood Line and Transducer Protector | Faridabad, Haryana |
| 10 | Majik Medical Solutions Pvt Ltd | Catheter Tubing (Cardiovascular) Micro-Catheter Tubing (Neurovascular) | Hyderabad, Telangana |
| 11 | Envision Scientific Private Limited | Stents and PTCA Ballon Catheter | Sachin, Surat, Gujarat |
| 12 | Innvolution Healthcare Pvt. Ltd. | Stents | Jaipur, Rajasthan & Vizag, A.P |
| 13 | Sahajanand Medical Technologies Private Limited | Stents, PTCA ballon Catheter | Surat,Gujarat and Sangareddy, Telangana |
Source: PIB
The post appeared first on .